Novel approach demonstrates targeted delivery improving cytotoxin activation, suggesting advancement in cancer therapy.
The success of antibody-drug conjugates illustrates the value of targeted delivery strategies for cytotoxic molecules. We present a novel approach to targeted delivery that uses intracellular covalent chemistry to selectively activate cytotoxins.
No takes yet. Share an insight, caveat, or question.
Schild et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: